Evidence map›Paper›PMID 32883308›Full record

ArticleMalaria journal2020

Utility of ultra-sensitive qPCR to detect Plasmodium falciparum and Plasmodium vivax infections under different transmission intensities.

Maria Gruenberg, Clara Antunes Moniz, Natalie E Hofmann, Cristian Koepfli, Leanne J Robinson, Elma Nate, Wuelton Marcelo Monteiro, Gisely Cardoso de Melo, Andrea Kuehn, Andre M Siqueira and 6 more

Abstract readComparative Study
In one paragraph

Article in Malaria journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Diagnostic performance of NxTekMalaria journal · 2023
    Article
  8. Article
  9. Article
  10. Evolutionary genetics of malaria.Frontiers in genetics · 2022
    Article
  11. Article
  12. An Ultra-Sensitive Technique: UsingPathogens (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Maria GruenbergSwiss Tropical and Public Health Institute, Basel, Switzerland.
Clara Antunes MonizSwiss Tropical and Public Health Institute, Basel, Switzerland.
Natalie E HofmannSwiss Tropical and Public Health Institute, Basel, Switzerland.
Cristian KoepfliWalter and Eliza Hall Institute of Medical Research, Melbourne, Australia.
Leanne J RobinsonPapua New Guinea Institute of Medical Research, Madang, Papua New Guinea.
Elma NatePapua New Guinea Institute of Medical Research, Madang, Papua New Guinea.
Wuelton Marcelo MonteiroFundação de Medicina Tropical Dr. Heitor Vieira Dourado (FMT-HVD), Manaus, Brazil.
Gisely Cardoso de MeloFundação de Medicina Tropical Dr. Heitor Vieira Dourado (FMT-HVD), Manaus, Brazil.
Andrea KuehnFundação de Medicina Tropical Dr. Heitor Vieira Dourado (FMT-HVD), Manaus, Brazil.
Andre M SiqueiraFundação de Medicina Tropical Dr. Heitor Vieira Dourado (FMT-HVD), Manaus, Brazil.
Wang NguitragoolDepartment of Molecular Tropical Medicine & Genetics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Quique BassatISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Marcus LacerdaFundação de Medicina Tropical Dr. Heitor Vieira Dourado (FMT-HVD), Manaus, Brazil.
Jetsumon SattabongkotMahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Ivo MuellerWalter and Eliza Hall Institute of Medical Research, Melbourne, Australia.
Ingrid FelgerSwiss Tropical and Public Health Institute, Basel, Switzerland. ingrid.felger@unibas.ch.ORCID http://orcid.org/0000-0003-1255-2606

Funding

Bill and Melinda Gates Foundation OPP1034577NIH HHS U19 AI089686-01Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 310030_159580Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung IZRJZ3_164182
6 · The paper itself

Abstract

backgroundThe use of molecular diagnostics has revealed an unexpectedly large number of asymptomatic low-density malaria infections in many malaria endemic areas. This study compared the gains in parasite prevalence obtained by the use of ultra-sensitive (us)-qPCR as compared to standard qPCR in cross-sectional surveys conducted in Thailand, Brazil and Papua New Guinea (PNG). The compared assays differed in the copy number of qPCR targets in the parasite genome.

methodsPlasmodium falciparum (Pf) and Plasmodium vivax (Pv) parasites were quantified by qPCR amplifying the low-copy Pf_ and Pv_18S rRNA genes or the multi-copy targets Pf_varATS and Pv_mtCOX1. Cross-sectional surveys at the three study sites included 2252 participants of all ages and represented different transmission intensities.

resultsIn the two low-transmission areas, P. falciparum positivity was 1.3% (10/773) (Thailand) and 0.8% (5/651) (Brazil) using standard Pf_18S rRNA qPCR. In these two countries, P. falciparum positivity by Pf_varATS us-qPCR increased to 1.9% (15/773) and 1.7% (11/651). In PNG, an area with moderate transmission intensity, P. falciparum positivity significantly increased from 8.6% (71/828) by standard qPCR to 12.2% (101/828) by us-qPCR. The proportions of P. falciparum infections not detected by standard qPCR were 33%, 55% and 30% in Thailand, Brazil and PNG. Plasmodium vivax was the predominating species in Thailand and Brazil, with 3.9% (30/773) and 4.9% (32/651) positivity by Pv_18S rRNA qPCR. In PNG, P. vivax positivity was similar to P. falciparum, at 8.0% (66/828). Use of Pv_mtCOX1 us-qPCR led to a significant increase in positivity to 5.1% (39/773), 6.4% (42/651) and 11.5% (95/828) in Thailand, Brazil, and PNG. The proportions of P. vivax infections missed by standard qPCR were similar at all three sites, with 23%, 24% and 31% in Thailand, Brazil and PNG.

conclusionThe proportional gains in the detection of P. falciparum and P. vivax infections by ultra-sensitive diagnostic assays were substantial at all three study sites. Thus, us-qPCR yields more precise prevalence estimates for both P. falciparum and P. vivax at all studied levels of endemicity and represents a significant diagnostic improvement. Improving sensitivity in P. vivax surveillance by us-qPCR is of particular benefit, because the additionally detected P. vivax infections signal the potential presence of hypnozoites and subsequent risk of relapse and further transmission.

Indexed as

BrazilCross-Sectional StudiesMalaria, FalciparumMalaria, VivaxPapua New GuineaPlasmodium falciparumPlasmodium vivaxPrevalenceReverse Transcriptase Polymerase Chain ReactionSensitivity and SpecificityThailandLow-densityMolecular diagnosticsmtCOX1qPCRUltra-sensitivevarATS

Identifiers

PMID32883308
PMCPMC7469345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.